{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T01:15:46Z","timestamp":1793063746991,"version":"4.5.0"},"reference-count":45,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,10,1]],"date-time":"2016-10-01T00:00:00Z","timestamp":1475280000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,10,1]],"date-time":"2016-10-01T00:00:00Z","timestamp":1475280000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2016,10,1]],"date-time":"2016-10-01T00:00:00Z","timestamp":1475280000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2016,10,1]],"date-time":"2016-10-01T00:00:00Z","timestamp":1475280000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2016,10,1]],"date-time":"2016-10-01T00:00:00Z","timestamp":1475280000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2016,10,1]],"date-time":"2016-10-01T00:00:00Z","timestamp":1475280000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2016,10,1]],"date-time":"2016-10-01T00:00:00Z","timestamp":1475280000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine & Pharmacotherapy"],"published-print":{"date-parts":[[2016,10]]},"DOI":"10.1016\/j.biopha.2016.08.011","type":"journal-article","created":{"date-parts":[[2016,8,11]],"date-time":"2016-08-11T15:04:29Z","timestamp":1470927869000},"page":"967-974","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":58,"special_numbering":"C","title":["Kaempferol inhibits fibroblast collagen synthesis, proliferation and activation in hypertrophic scar via targeting TGF-\u03b2 receptor type I"],"prefix":"10.1016","volume":"83","author":[{"given":"Hongwei","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liu","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuebing","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhigang","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"8","key":"10.1016\/j.biopha.2016.08.011_bib0005","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1111\/exd.13014","article-title":"Prostaglandin E inhibits collagen synthesis in dermal fibroblasts and prevents hypertrophic scar formation in vivo","volume":"25","author":"Zhao","year":"2016","journal-title":"Exp. Dermatol."},{"issue":"12","key":"10.1016\/j.biopha.2016.08.011_bib0010","doi-asserted-by":"crossref","first-page":"1745","DOI":"10.1111\/dsu.12346","article-title":"Intralesional treatment for keloids and hypertrophic scars: a review","volume":"39","author":"Ledon","year":"2013","journal-title":"Dermatol. Surg."},{"issue":"6","key":"10.1016\/j.biopha.2016.08.011_bib0015","doi-asserted-by":"crossref","first-page":"817","DOI":"10.2217\/rme.14.54","article-title":"Wound healing: an update","volume":"9","author":"Zielins","year":"2014","journal-title":"Regen. Med."},{"issue":"5","key":"10.1016\/j.biopha.2016.08.011_bib0020","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1097\/00006534-199910000-00031","article-title":"On the nature of hypertrophic scars and keloids: a review","volume":"104","author":"Niessen","year":"1999","journal-title":"Plast. Reconstr. Surg."},{"issue":"2","key":"10.1016\/j.biopha.2016.08.011_bib0025","doi-asserted-by":"crossref","first-page":"e31157","DOI":"10.1371\/journal.pone.0031157","article-title":"Therapeutic effects of liposome-enveloped Ligusticum chuanxiong essential oil on hypertrophic scars in the rabbit ear model","volume":"7","author":"Zhang","year":"2012","journal-title":"PLoS One"},{"issue":"5","key":"10.1016\/j.biopha.2016.08.011_bib0030","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1111\/1346-8138.12792","article-title":"MiR-138\/peroxisome proliferator-activated receptor beta signaling regulates human hypertrophic scar fibroblast proliferation and movement in vitro","volume":"42","author":"Xiao","year":"2015","journal-title":"J. Dermatol."},{"issue":"2","key":"10.1016\/j.biopha.2016.08.011_bib0035","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1111\/j.1365-2133.2010.10035.x","article-title":"The role of stem cell factor and c-KIT in keloid pathogenesis: do tyrosine kinase inhibitors have a potential therapeutic role?","volume":"164","author":"Mukhopadhyay","year":"2011","journal-title":"Br. J. Dermatol."},{"issue":"7380","key":"10.1016\/j.biopha.2016.08.011_bib0040","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1136\/bmj.326.7380.88","article-title":"Skin scarring","volume":"326","author":"Bayat","year":"2003","journal-title":"BMJ"},{"issue":"Suppl. 1","key":"10.1016\/j.biopha.2016.08.011_bib0045","first-page":"s10","article-title":"Mechanisms of pathological scarring: role of myofibroblasts and current developments","volume":"19","author":"Sarrazy","year":"2011","journal-title":"Wound Repair. Regen."},{"key":"10.1016\/j.biopha.2016.08.011_bib0050","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.lfs.2016.03.009","article-title":"Kaempferol targets Krt-14 and induces cytoskeletal mineralization in osteoblasts: a mechanistic approach","volume":"151","author":"Khedgikar","year":"2016","journal-title":"Life Sci."},{"key":"10.1016\/j.biopha.2016.08.011_bib0055","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.phrs.2015.05.002","article-title":"Kaempferol and inflammation: from chemistry to medicine","volume":"99","author":"Devi","year":"2015","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.biopha.2016.08.011_bib0060","doi-asserted-by":"crossref","first-page":"481405","DOI":"10.1155\/2015\/481405","article-title":"Protective effects of kaempferol against myocardial ischemia\/reperfusion injury in isolated rat heart via antioxidant activity and inhibition of glycogen synthase kinase-3beta","volume":"2015","author":"Zhou","year":"2015","journal-title":"Oxid. Med. Cell Longev."},{"issue":"5","key":"10.1016\/j.biopha.2016.08.011_bib0065","doi-asserted-by":"crossref","first-page":"2007","DOI":"10.3892\/ijo.2016.3420","article-title":"Kaempferol induces ATM\/p53-mediated death receptor and mitochondrial apoptosis in human umbilical vein endothelial cells","volume":"48","author":"Lee","year":"2016","journal-title":"Int. J. Oncol."},{"issue":"1","key":"10.1016\/j.biopha.2016.08.011_bib0070","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1016\/j.intimp.2015.07.018","article-title":"Kaempferol alleviates insulin resistance via hepatic IKK\/NF-kappaB signal in type 2 diabetic rats","volume":"28","author":"Luo","year":"2015","journal-title":"Int. Immunopharmacol."},{"issue":"17","key":"10.1016\/j.biopha.2016.08.011_bib0075","doi-asserted-by":"crossref","first-page":"3750","DOI":"10.1021\/jf405486c","article-title":"Aceriphyllum rossii extract and its active compounds, quercetin and kaempferol inhibit IgE-mediated mast cell activation and passive cutaneous anaphylaxis","volume":"62","author":"Kim","year":"2014","journal-title":"J. Agric. Food Chem."},{"issue":"4","key":"10.1016\/j.biopha.2016.08.011_bib0080","doi-asserted-by":"crossref","first-page":"600","DOI":"10.18433\/J34W39","article-title":"Flavonols protect against UV radiation-induced thymine dimer formation in an artificial skin mimic","volume":"18","author":"Maini","year":"2015","journal-title":"J. Pharm. Pharm. Sci."},{"key":"10.1016\/j.biopha.2016.08.011_bib0085","article-title":"Keloids and hypertrophic scars: pathophysiology, classification, and treatment","author":"Berman","year":"2016","journal-title":"Dermatol. Surg."},{"issue":"1","key":"10.1016\/j.biopha.2016.08.011_bib0090","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1097\/00006534-200207000-00029","article-title":"Effect of Mederma on hypertrophic scarring in the rabbit ear model","volume":"110","author":"Saulis","year":"2002","journal-title":"Plast. Reconstr. Surg."},{"issue":"11","key":"10.1016\/j.biopha.2016.08.011_bib0095","first-page":"1507","article-title":"An open, randomized, controlled, comparative study of the combined effect of intralesional triamcinolone acetonide and onion extract gel and intralesional triamcinolone acetonide alone in the treatment of hypertrophic scars and keloids","volume":"34","author":"Koc","year":"2008","journal-title":"Dermatol. Surg."},{"issue":"6","key":"10.1016\/j.biopha.2016.08.011_bib0100","doi-asserted-by":"crossref","first-page":"1212","DOI":"10.1097\/01.TA.0000030630.72836.32","article-title":"Dietary compounds inhibit proliferation and contraction of keloid and hypertrophic scar-derived fibroblasts in vitro: therapeutic implication for excessive scarring","volume":"54","author":"Phan","year":"2003","journal-title":"J. Trauma."},{"issue":"12","key":"10.1016\/j.biopha.2016.08.011_bib0105","doi-asserted-by":"crossref","first-page":"3250","DOI":"10.1096\/fj.07-8218com","article-title":"Mechanical load initiates hypertrophic scar formation through decreased cellular apoptosis","volume":"21","author":"Aarabi","year":"2007","journal-title":"FASEB J."},{"issue":"7","key":"10.1016\/j.biopha.2016.08.011_bib0110","doi-asserted-by":"crossref","first-page":"2415","DOI":"10.1073\/pnas.0712168105","article-title":"A chemical method for fast and sensitive detection of DNA synthesis in vivo","volume":"105","author":"Salic","year":"2008","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"8","key":"10.1016\/j.biopha.2016.08.011_bib0115","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1177\/1087057109339207","article-title":"Development and applications of a broad-coverage, TR-FRET-based kinase binding assay platform","volume":"14","author":"Lebakken","year":"2009","journal-title":"J. Biomol. Screen."},{"issue":"1\u20132","key":"10.1016\/j.biopha.2016.08.011_bib0120","first-page":"109","article-title":"Galangin inhibits hypertrophic scar formation via ALK5\/Smad2\/3 signaling pathway","volume":"413","author":"Zhang","year":"2016","journal-title":"Mol. Cell. Biochem."},{"issue":"1","key":"10.1016\/j.biopha.2016.08.011_bib0125","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1016\/j.bbrc.2014.06.016","article-title":"A heterocyclic molecule kartogenin induces collagen synthesis of human dermal fibroblasts by activating the smad4\/smad5 pathway","volume":"450","author":"Wang","year":"2014","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"3","key":"10.1016\/j.biopha.2016.08.011_bib0130","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1038\/sj.jid.5700613","article-title":"Formation and function of the myofibroblast during tissue repair","volume":"127","author":"Hinz","year":"2007","journal-title":"J. Invest. Dermatol."},{"issue":"3","key":"10.1016\/j.biopha.2016.08.011_bib0135","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1111\/j.1365-2133.2009.09511.x","article-title":"Mechanisms of transforming growth factor beta(1)\/Smad signalling mediated by mitogen-activated protein kinase pathways in keloid fibroblasts","volume":"162","author":"He","year":"2010","journal-title":"Br. J. Dermatol."},{"issue":"7","key":"10.1016\/j.biopha.2016.08.011_bib0140","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1016\/S0092-8674(00)80303-7","article-title":"The MAD-related protein Smad7 associates with the TGFbeta receptor and functions as an antagonist of TGFbeta signaling","volume":"89","author":"Hayashi","year":"1997","journal-title":"Cell"},{"issue":"7","key":"10.1016\/j.biopha.2016.08.011_bib0145","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1016\/j.burns.2014.02.011","article-title":"Up-to-date approach to manage keloids and hypertrophic scars: a useful guide","volume":"40","author":"Arno","year":"2014","journal-title":"Burns"},{"issue":"1","key":"10.1016\/j.biopha.2016.08.011_bib0150","first-page":"105","article-title":"Morphological and immunochemical differences between keloid and hypertrophic scar","volume":"145","author":"Ehrlich","year":"1994","journal-title":"Am. J. Pathol."},{"issue":"6","key":"10.1016\/j.biopha.2016.08.011_bib0155","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1001\/archfaci.8.6.362","article-title":"Treatment of keloids and hypertrophic scars: a meta-analysis and review of the literature","volume":"8","author":"Leventhal","year":"2006","journal-title":"Arch. Facial Plast. Surg."},{"issue":"5","key":"10.1016\/j.biopha.2016.08.011_bib0160","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1111\/j.1365-2133.2011.10492.x","article-title":"Laser and intense pulsed light therapy for the treatment of hypertrophic scars: a systematic review","volume":"165","author":"Vrijman","year":"2011","journal-title":"Br. J. Dermatol."},{"issue":"1","key":"10.1016\/j.biopha.2016.08.011_bib0165","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.bjps.2007.10.052","article-title":"The effectiveness of pressure garment therapy for the prevention of abnormal scarring after burn injury: a meta-analysis","volume":"62","author":"Anzarut","year":"2009","journal-title":"J. Plast. Reconstr. Aesthet. Surg."},{"issue":"1","key":"10.1016\/j.biopha.2016.08.011_bib0170","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.burns.2004.06.018","article-title":"Pressure garments for use in the treatment of hypertrophic scars\u2013a review of the problems associated with their use","volume":"32","author":"Macintyre","year":"2006","journal-title":"Burns"},{"issue":"4","key":"10.1016\/j.biopha.2016.08.011_bib0175","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.1097\/PRS.0b013e318185d38f","article-title":"Scars: a review of emerging and currently available therapies","volume":"122","author":"Reish","year":"2008","journal-title":"Plast. Reconstr. Surg."},{"key":"10.1016\/j.biopha.2016.08.011_bib0180","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1007\/978-1-62703-505-7_11","article-title":"Novel methods for the investigation of human hypertrophic scarring and other dermal fibrosis","volume":"1037","author":"Honardoust","year":"2013","journal-title":"Methods Mol. Biol."},{"issue":"5","key":"10.1016\/j.biopha.2016.08.011_bib0185","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1111\/j.1365-2990.2007.00910.x","article-title":"Alpha-smooth muscle actin (alpha-SMA) and nestin expression in reactive astrocytes in multiple sclerosis lesions: potential regulatory role of transforming growth factor-beta 1 (TGF-beta1)","volume":"34","author":"Moreels","year":"2008","journal-title":"Neuropathol. Appl. Neurobiol."},{"issue":"3","key":"10.1016\/j.biopha.2016.08.011_bib0190","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1038\/labinvest.2013.137","article-title":"Inhibition of airway epithelial-to-mesenchymal transition and fibrosis by kaempferol in endotoxin-induced epithelial cells and ovalbumin-sensitized mice","volume":"94","author":"Gong","year":"2014","journal-title":"Lab. Invest."},{"issue":"7193","key":"10.1016\/j.biopha.2016.08.011_bib0195","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1038\/nature07039","article-title":"Wound repair and regeneration","volume":"453","author":"Gurtner","year":"2008","journal-title":"Nature"},{"issue":"2","key":"10.1016\/j.biopha.2016.08.011_bib0200","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1111\/exd.12897","article-title":"Aberrant Notch signalling contributes to hypertrophic scar formation by modulating the phenotype of keratinocytes","volume":"25","author":"Li","year":"2016","journal-title":"Exp. Dermatol."},{"issue":"2","key":"10.1016\/j.biopha.2016.08.011_bib0205","doi-asserted-by":"crossref","first-page":"208","DOI":"10.3858\/emm.2008.40.2.208","article-title":"Transcriptional profiling in human HaCaT keratinocytes in response to kaempferol and identification of potential transcription factors for regulating differential gene expression","volume":"40","author":"Kang","year":"2008","journal-title":"Exp. Mol. Med."},{"issue":"7","key":"10.1016\/j.biopha.2016.08.011_bib0210","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1096\/fj.03-1273rev","article-title":"TGF-beta signaling and the fibrotic response","volume":"18","author":"Leask","year":"2004","journal-title":"FASEB J."},{"key":"10.1016\/j.biopha.2016.08.011_bib0215","first-page":"619","article-title":"Protective effect of fucoidan from Fucus vesiculosus on liver fibrosis via the TGF-beta1\/Smad pathway-mediated inhibition of extracellular matrix and autophagy","volume":"10","author":"Li","year":"2016","journal-title":"Drug Des. Dev. Ther."},{"issue":"6","key":"10.1016\/j.biopha.2016.08.011_bib0220","doi-asserted-by":"crossref","first-page":"1758","DOI":"10.1016\/j.ajpath.2013.08.014","article-title":"ERK5 inhibition ameliorates pulmonary fibrosis via regulating Smad3 acetylation","volume":"183","author":"Kim","year":"2013","journal-title":"Am. J. Pathol."},{"issue":"3","key":"10.1016\/j.biopha.2016.08.011_bib0225","doi-asserted-by":"crossref","first-page":"e0121312","DOI":"10.1371\/journal.pone.0121312","article-title":"Suppression of TGF-beta1\/Smad signaling pathway by sesamin contributes to the attenuation of myocardial fibrosis in spontaneously hypertensive rats","volume":"10","author":"Zhao","year":"2015","journal-title":"PLoS One"}],"container-title":["Biomedicine & Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332216308277?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332216308277?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,23]],"date-time":"2026-04-23T11:37:57Z","timestamp":1776944277000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0753332216308277"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,10]]},"references-count":45,"alternative-id":["S0753332216308277"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2016.08.011","relation":{},"ISSN":["0753-3322"],"issn-type":[{"value":"0753-3322","type":"print"}],"subject":[],"published":{"date-parts":[[2016,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Kaempferol inhibits fibroblast collagen synthesis, proliferation and activation in hypertrophic scar via targeting TGF-\u03b2 receptor type I","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2016.08.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}